Increased glucose metabolism in neoplastic cells depends, inter alia, on their localization, increased expression of glucose transporting proteins from the glucose transporter (GLUT) family, enzymes such as phosphoglucomutase or hexokinase, the degree of cell proliferation, and the tumor vascularity [42]. The gene discussed is SLC2A1; the disease is neoplasm.